The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

Trial Profile

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jul 2017

At a glance

  • Drugs Rotavirus vaccine (Primary) ; Ciprofloxacin; Metronidazole; Pneumococcal vaccine; Tetanus vaccine; Vancomycin
  • Indications Pneumococcal infections; Rotavirus infections; Tetanus
  • Focus Pharmacodynamics
  • Acronyms Rota-biome
  • Most Recent Events

    • 24 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 24 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.
    • 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top